Literature DB >> 10336460

A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer.

P J Lu1, K Sundquist, D Baeckstrom, R Poulsom, A Hanby, S Meier-Ewert, T Jones, M Mitchell, P Pitha-Rowe, P Freemont, J Taylor-Papadimitriou.   

Abstract

A novel human gene (PLU-1) has been identified which shows a highly restricted expression in normal adult tissues but which is consistently expressed in breast cancers. A fragment of the PLU-1 cDNA was identified by differentially screening a fetal brain library with cDNAs prepared from ce-1 cells (a human mammary epithelial cell line overexpressing c-ErbB2) treated or untreated with the antibody 4D5, which inhibits c-ErbB2 phosphorylation. Clones covering the full cDNA sequence of 6.4 kilobases were isolated from a breast cancer cDNA library. Although expression of PLU-1 in ce-1 cells is regulated by signaling from c-ErbB2, the gene is expressed in all the breast cancer cell lines examined, in cells cultured from primary breast cancers, and in the invasive and in situ components of primary breast cancers. Translation of the open reading frame predicts a protein of 1544 amino acids, which contains three PHD/LAP motifs, a specific DNA-binding domain found in a Drosophila protein (dri) and novel domains showing extensive homology with other human and non human gene products. Transient transfection of cell lines with MYC-tagged PLU-1 showed the protein to be localized in the nucleus and associated with discrete foci. The presence of the dri motif and PHD/LAP fingers together with the clear nuclear localization and consistent expression in breast cancers, suggest a role for PLU-1 in regulating gene expression in breast cancers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336460     DOI: 10.1074/jbc.274.22.15633

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

Review 1.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

2.  JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.

Authors:  Yang Xiang; Ziqi Zhu; Gang Han; Xiaolei Ye; Bo Xu; Zhouchun Peng; Yuanjun Ma; Yi Yu; Hanqing Lin; Adele Pin Chen; Charlie Degui Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-28       Impact factor: 11.205

3.  KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.

Authors:  Zanabazar Enkhbaatar; Minoru Terashima; Dulamsuren Oktyabri; Shoichiro Tange; Akihiko Ishimura; Seiji Yano; Takeshi Suzuki
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

Review 4.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

5.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

Review 6.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

Authors:  Paul A C Cloos; Jesper Christensen; Karl Agger; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

7.  A novel protein with similarities to Rb binding protein 2 compensates for loss of Chk1 function and affects histone modification in fission yeast.

Authors:  Shakil Ahmed; Carmela Palermo; Shanhong Wan; Nancy C Walworth
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  JARID1B is a luminal lineage-driving oncogene in breast cancer.

Authors:  Shoji Yamamoto; Zhenhua Wu; Hege G Russnes; Shinji Takagi; Guillermo Peluffo; Charles Vaske; Xi Zhao; Hans Kristian Moen Vollan; Reo Maruyama; Muhammad B Ekram; Hanfei Sun; Jee Hyun Kim; Kristopher Carver; Mattia Zucca; Jianxing Feng; Vanessa Almendro; Marina Bessarabova; Oscar M Rueda; Yuri Nikolsky; Carlos Caldas; X Shirley Liu; Kornelia Polyak
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

9.  Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.

Authors:  Mike Ran Zou; Jian Cao; Zongzhi Liu; Sung Jin Huh; Kornelia Polyak; Qin Yan
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

10.  The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.

Authors:  Sophie Beyer; Malene Maag Kristensen; Kim Steen Jensen; Jens Vilstrup Johansen; Peter Staller
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.